Clinical Trial

A Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Wireless Brain-Computer Interface（BCI）System NEO in Patients With Tetraplegia

Study acronym: NEO
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 25, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the safety and efficacy of a Minimally Invasive Wireless Implantable Brain-Computer Interface (BCI) System NEO in patients with tetraplegia and to provide a basis for product registration. Through brain-computer interface alternative technology, patients can control the external equipment with brain signals to improve the patient's quality of life.
Trial Details
NCT Number NCT06990412
Lead Sponsor Neuracle Medical Technology(Shanghai) Co.,Ltd.
Collaborators: Huashan Hospital, Xuanwu Hospital, Beijing, The First Affiliated Hospital with Nanjing Medical University, First Affiliated Hospital of Fujian Medical University, Beijing Tiantan Hospital, Henan Provincial People's Hospital, West China Hospital, Affiliated Hospital of Nantong University, The General Hospital of Eastern Theater Command, Peking University Third Hospital, Xiangya Hospital of Central South University, Tongji Hospital
Conditions Tetraplegia, Spinal Cord Injuries (SCI)
Enrollment 32 participants
Start Date 2025-05-20
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-05-20 (estimated)
Updated on ClinicalTrials.gov 2025-05-25